Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will make an estimate of future trends in the level of prostate cancer rates up to May 2028.

An increase in prostate specific antigen (PSA) testing in recent years has led to increased prostate cancer diagnoses. However, it is worth noting that the increase in diagnosis has not impacted upon mortality rates.

We know that the best way to treat prostate cancer is by identifying it as early as possible. The Department is investing £16 million into the Prostate Cancer UK-led Transform screening trial, which seeks to find better ways to detect prostate cancer. This trial will compare the most promising tests that look for prostate cancer in men that do not have symptoms and aims to address disparities in detection rates across different groups. This will contribute to our further understanding of prostate cancer including its prevalence. The National Cancer Plan will include further details on how we will improve outcomes for cancer patients, including those living with prostate cancer.